No Data
No Data
Express News | NYSE Order Imbalance 378924.0 Shares on Buy Side
Express News | Solventum Corp : Goldman Sachs Initiates Coverage With Sell Rating; Price Target $54
Stock Ratings for Solventum and GE HealthCare Offer a Lesson About Spinoffs -- Barrons.com
Al Root The latest Wall Street ratings on the healthcare companies Solventum and GE HealthCare Technologies offer a master's class in what to look for in shares of spinoff companies -- and which of t
Solventum Initiated at Sell by Goldman Sachs
Solventum Initiated at Sell by Goldman Sachs
Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target
Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target.
Is 3M Spinoff Solventum a Buy? (And What It Means for 3M Investors)
It's always interesting when a new company comes to market and doubly interesting when it's a spinoff. In reality, two new companies came out of the spinoff of Solventum (SOLV -1.41%) and 3M (MMM 3.58%) -- a newly created healthcare company and an industrial conglomerate without a healthcare business.
No Data